Like Envision Pharma, Inc.

closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2009 via PR Newswire

Pharmaceutical Institute, acquired GeneEd, Inc.

synopsis: Pharmaceutical Institute announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.
buyer parent: Campbell Alliance Group, Inc.
buyer: Pharmaceutical Institute
Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry. They partner with subject matter experts from Campbell Alliance, the parent company, to develop highly impactful dstance learning solutions for pharma professionals. "
target: GeneEd, Inc.
GeneEd is a provider of life science e-learning content.Two scientists and a retired venture capitalist founded GeneEd in 1997. Dr. Sunil Maulik and Dr. Salil Patel have more than 15 years of industry and teaching experience at Roche Bioscience, Doubletwist and other life science companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/30/2020 via BNC Analysis

ResMed, will acquire Snapworx, LLC

synopsis: ResMed announced that it agreed to acquire SnapWorx, a privately held software company providing patient contact management and workflow optimization for the sleep apnea resupply market. SnapWorx's software platform automates workflow and document retrieval.
buyer: ResMed (RMD:$2,784.41)
ResMed, a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. "
target: Snapworx, LLC
SnapWorx, a privately held software company providing patient contact management and workflow optimization for the sleep apnea resupply market. SnapWorx’s software platform automates workflow and document retrieval.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2021 via BNC Analysis

Vespa Capital, acquired SelectScience

synopsis: Vespa Capital, a UK private equity investor, has acquired SelectScience Limited. Bath based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
buyer: Vespa Capital
Vespa Capital is an established Private Equity investor in the UK lower mid-market. With over £200m of funds under management, they focus on Management Buy Outs and recapitalisations of privately owned businesses with an Enterprise Value between £10m and £70m. "
target: SelectScience
Bath-based SelectScience was founded by Arif and Louise Butt over 20 years ago and has become one of the world’s leading, independent digital publishers providing reputable science technology and research news and trusted product reviews.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/29/2011 via Market Wire

CompareNetworks, Inc., acquired Russell Publishing LLC

synopsis: CompareNetworks, Inc. announced the acquisition of Russell Publishing LLC, complementing the company's innovative online marketplaces with industry-leading pharmaceutical publications. Russell Publishing's titles include American Pharmaceutical Review, Pharmaceutical Outsourcing and International Drug Discovery.
buyer parent: Alta Communications
buyer: CompareNetworks, Inc.
CompareNetworks operates targeted, online, B2B marketplaces for professionals worldwide. The company integrates online marketplaces, email newsletters, award-winning video, whitepapers and editorial content to bring buyers and sellers together. "
target: Russell Publishing LLC
Russell Publishing LLC, a privately held company founded in 1998 and based in Indianapolis, IN, is one of the leading publishers of life science B2B publications in the world. The company's three titles and websites cover all aspects of the pharmaceutical and biopharmaceutical pipeline.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2010 via BusinessWire

Canon Communications, LLC, acquired Pharmalot

synopsis: Canon Communications LLC, announced that it has acquired Pharmalot. As part of the acquisition, Pharmalot’s founder, Ed Silverman, will join Canon as an Editor at Large in the Pharmaceutical Media Group and will continue as Pharmalot’s Editor.
buyer parent: Spectrum Equity Investors
buyer: Canon Communications, LLC
Canon Communications LLC produces tradeshows and conferences for both U.S. and international markets. Canon also publishes magazines and digital media for medical devices, microelectronics, plastics processing, packaging, and other advanced design and manufacturing markets. "
target: Pharmalot
Pharmalot is an influential blog focused on news and information in the pharmaceutical industry. Pharmalot is written by Ed Silverman, a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via Market Wire

Bio-IT World, acquired OpenHelix, LLC

synopsis: OpenHelix, a provider of online and onsite training on some of the most popular and powerful open-access bioinformatics resources on the web, will join the Cambridge Healthtech Institute as a division of Bio-IT World, a leading source of news and opinion on technology and strategic innovation in the life sciences.
buyer parent: Cambridge Healthtech Institute
buyer: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals. "
target: OpenHelix, LLC
OpenHelix, a Washington State company, was founded in 2003 to provide training on what was then a fledgling but quickly growing market of open access web based bioinformatics resources.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/3/2013 via Company Press Release

Thomson Reuters, acquired BioWorld

synopsis: BioWorld and its companion publication Medical Device Daily (MDD) have been acquired by Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals. BioWorld covers news on public companies and hard-to-find information on private companies.
buyer: Thomson Reuters (TRI:$5,921.00)
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. It combines industry expertise with innovative technology to deliver critical information to leading decision makers. "
target parent: Thompson Media Group LLC
target: BioWorld
BioWorld covers news on public companies and hard-to-find information on private companies. This news coverage of the biotechnology industry is 100 percent original and available only at BioWorld.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2006 via Company Press Release

Cambridge Heathtech Institute, acquired Bio-IT World

synopsis: Cambridge Healthtech Institute of Newton today announced the acquisition of Bio-IT World, Inc.’s media and events properties. The flagship publication, Bio-IT World magazine, introduced in March 2002, has grown from a 10-times-per-year publication to include a range of online and event businesses.
buyer: Cambridge Heathtech Institute
Cambridge Healthtech Institute’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk and the World Pharmaceutical Congress. "
target parent: International Data Group
target: Bio-IT World
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life sciences, healthcare, pharmaceutical and regulatory professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via Company Press Release

Decision Resources, Inc., acquired Fingertip Formulary

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare industry insight and analysis, announced that it acquired Fingertip Formulary, the leading provider of access to and insight into formulary data in the United States.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Fingertip Formulary
Fingertip Formulary offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others, in the United States. Fingertip Formulary offers a variety of unique data and marketing solutions that provide access to and insight into formulary data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/11/2020 via BNC Analysis

Huntsworth PLC, will acquire Nucleus Global

synopsis: Huntsworth, an international healthcare and communications group, will acquire UK-based Nucleus Global, one of the world’s largest medical specialist communications groups. The addition of Nucleus Global to Huntsworth creates one of the largest high science teams in the world to meet the needs of next-generation prescription drug development.
buyer parent: Clayton, Dubilier & Rice, Inc.
buyer: Huntsworth PLC (LSE:HNT:$342.69)
UK-based Huntsworth is an international healthcare and communications group. The Group's principal areas of focus are marketing, medical, and immersive communications services to healthcare clients, which are primarily large and mid-size pharmaceutical and biotech companies. "
target: Nucleus Global
UK-based Nucleus Global is a medical communications group that provides strategic communications, publications planning, experts and patients engagement, scientific events management, medical education, internal communications, trainings, and more for pharmaceutical and biotechnology companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2019 via PR Newswire

Crain Communications, Inc., acquired Genomeweb LLC

synopsis: Crain Communications Inc has acquired GenomeWeb, an online news organization serving the global community of scientists, technology professionals and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb was launched in 1997 and has a staff of 30 employees located in New York.
buyer: Crain Communications, Inc.
Crain Communications is a privately held media company that produces trusted and relevant news publications, lead generation, research and data products, digital platforms, custom publishing, and events with uncompromising integrity. "
target: Genomeweb LLC
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/8/2016 via Company Press Release

ERT, acquired Exco InTouch, Ltd.

synopsis: ERT announced the acquisition of Exco InTouch, a leading provider of patient engagement, data capture and digital health solutions. The combined organization will provide the biopharmaceutical industry with the most advanced and comprehensive choice for electronic clinical outcome assessments (eCOA), patient engagement and digital health.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: Exco InTouch, Ltd.
Exco InTouch is a leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers. Exco InTouch solutions provide simple, secure channels of communication; facilitating the collection of quality data and improving outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/22/2016 via PR Newswire

The WIRB-Copernicus Group, acquired CenterWatch, Inc.

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information. CenterWatch provides clinical trials information to clinical research professionals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
target: CenterWatch, Inc.
CenterWatch is the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs, to investigative sites, technology solutions and niche providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2012 via BusinessWire

Trifecta Multimedical, acquired Virtual Clinical Solutions, Inc.

synopsis: Trifecta Multimedical, one of the largest global providers of online clinical training solutions, announced the acquisition of Virtual Clinical Solutions (VCS). VCS is a specialist in providing virtual meetings and on-demand training content for the healthcare and pharmaceutical industries.
buyer: Trifecta Multimedical
Trifecta Multimedical is a global leader in online investigator training. Trifecta Multimedical’s solutions have been proven to decrease time for site readiness, accelerate enrollment and improve communication between sponsors, sites and clinical research associates on hundreds of clinical trials. "
target: Virtual Clinical Solutions, Inc.
A leading global provider of online clinical training solutions, Virtual Clinical Solutions provides services in 120 countries, specializing in the delivery of efficient, cost-effective training of investigational sites and study teams, through virtual meetings and on-demand training content.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/24/2021 via BNC Analysis

Envision Pharma Group, acquired doDOC Corp.

synopsis: Envision Pharma Group, a leading global technology-enabled scientific communications company, is pleased to announce the acquisition of doDOC Corp., a leader in document collaborative review, editing, and authoring. doDoc was founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal.
buyer parent: GHO Capital
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: doDOC Corp.
Founded by MIT alumni in 2015 in Boston, MA, and with a European base in Coimbra, Portugal, doDOC has the mission to transform the way life sciences teams write and review their documents, offering cloud-based software for enterprise documentation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/9/2020 via BNC Analysis

Envision Pharma Group, acquired 90Ten

synopsis: Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition of 90TEN extends Envision’s footprint in patient engagement and medical communications with its behavioral science methodology.
buyer parent: Ardian
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: 90Ten
90TEN is a global healthcare communications consultancy that aims to make people healthier and happier through education and communications. The company provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/19/2013 via BusinessWire

Halifax Group, acquired Envision Pharma, Inc.

synopsis: The Halifax Group, a leading middle-market private equity firm, announced that it has acquired Envision Pharma, Inc. from a subsidiary of Express Scripts Holding Co. Envision is an innovative global technology and scientific communication company focused on the pharmaceutical, biotechnology and medical device industries.
buyer: Halifax Group
The Halifax Group is a private equity firm that invests between $10 and $40 million alongside owners and managers of established, growing and profitable companies that are leaders in their market niche. "
target parent: Express Scripts Inc.
target: Envision Pharma, Inc.
Envision Pharma, founded in 2001, is an innovative global technology and scientific communication company serving pharmaceutical, biotechnology and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/24/2020 via GlobeNewswire

Ardian, will acquire PRGX Global, Inc.

synopsis: Ardian, a world-leading private investment house based in France, will acquire PRGX Global, Inc., a global leader in recovery audit and spend analytics services. PRGX provides technology-enabled source-to-pay solutions to clients across industries, including retail, grocery, consumer packaged goods, manufacturing, and pharmaceuticals, among others.
buyer: Ardian
Headquartered in France, Ardian is a world-leading private investment house with assets of US$103 billion managed or advised in Europe, the Americas, and Asia. Ardian focuses on delivering excellent investment performance to its global investor base. "
target: PRGX Global, Inc. (PRGX:$164.07)
PRGX Global is a global leader in Recovery Audit and Spend Analytics services. Having identified more than 300 common points of leakage, PRGX helps companies reach wider, dig deeper, and act faster to get more value out of their source-to-pay data.
price ($mm)[EV]
$194 [$212]
rev ($mm)
$164
EBITDA ($mm)
$24
EV / rev
1.3x
EV / EBITDA
8.7x
closed 12/18/2020 via Company Press Release

Ardian, acquired AD Education SAS

synopsis: Ardian, a world-leading French private equity house, has acquired a majority stake in AD Education alongside Kevin Guenegan, founder and CEO of the group, as well as the management team. Based in Paris, AD Education is a leading European higher education platform and a leader in the field of Creative Arts.
buyer: Ardian
Headquartered in France, Ardian is a world-leading private investment house with assets of US$103 billion managed or advised in Europe, the Americas, and Asia. Ardian focuses on delivering excellent investment performance to its global investor base. "
target: AD Education SAS
Based in Paris, AD Education is a leading European higher education platform and a leader in the field of Creative Arts. AD Education covers four main sub-segments: Design & Graphical Arts, Media & Digital, Audiovisual, and Culture & Luxury.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/11/2020 via BNC Analysis

A Consortium of 4 Buyers acquired Envision Pharma Group

synopsis: GHO Capital, together with Mubadala Investment Company, the Abu Dhabi-based sovereign investor, and including HarbourVest Partners and Northwestern Mutual, acquired the majority stake in Envision from Ardian SAS, a Paris-based global buyout firm. Envision Pharma Group is a global technology and scientific communications.
buyer: Mubadala Investment Company
buyer: HarbourVest Partners, LLC
buyer: GHO Capital
buyer: Northwestern Mutual
GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. Mubadala is a pioneering global investor. HarbourVest is an independent, global private markets asset manager. Northwestern Mutual helps families and businesses achieve financial security. "
target parent: Ardian
target: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/21/2020 via BusinessWire

Dedalus S.p.A., will purchase Healthcare Provider Software Business from DXC Technology Company

synopsis: DXC Technology will sell DXC’s healthcare software provider business, a leader in the healthcare sector, to the Italy-based Dedalus Group. Among the healthcare provider software business' innovations is an open digital health platform that helps improve care outcomes by delivering contextual and actionable insights across the healthcare ecosystem.
buyer parent: Ardian
buyer: Dedalus S.p.A.
Headquartered in Florence, Italy, Dedalus Group is the leading healthcare and diagnostic software provider in Europe and one of the largest in the world. Dedalus engages in the design and global redesign of clinical and healthcare processes at the international level. "
seller: DXC Technology Company (DXC:$18,892.00)
DXC’s healthcare provider software business is a recognized leader in the healthcare sector. Among its innovations is an open digital health platform that helps improve care outcomes by delivering contextual and actionable insights across the healthcare ecosystem.
price ($mm)
$525
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/9/2020 via BNC Analysis

Envision Pharma Group, acquired 90Ten

synopsis: Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition of 90TEN extends Envision’s footprint in patient engagement and medical communications with its behavioral science methodology.
buyer parent: Ardian
buyer: Envision Pharma Group
Envision Pharma Group is a global technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions through its iEnvision platform. "
target: 90Ten
90TEN is a global healthcare communications consultancy that aims to make people healthier and happier through education and communications. The company provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/5/2019 via GlobeNewswire

TELUS International, will acquire Competence Call Center Group (CCC)

synopsis: TELUS Corporation, through TELUS International, a customer experience innovator that designs, builds and delivers next-generation digital solutions for global brands, has agreed to acquire Competence Call Center (CCC), a leading provider of higher-value-added business services with a focus on customer relationship management and content moderation.
buyer parent: TELUS Corporation
buyer: TELUS International
Based in Canada, TELUS International is a leading global business process and IT services company. TELUS International enables customer experience innovation through spirited teamwork, agile thinking, and a caring culture that puts customers first. The company serves clients in over 35 languages. "
target parent: Ardian
target: Competence Call Center Group (CCC)
Competence Call Center Group (CCC) is one of the leading BPO service providers in Europe. Founded in Austria in 1998, CCC is today headquartered in Berlin. and offers high-quality BPO solutions in 28 languages and serves more than 80 customers in Europe.
price ($mm)
$1,008
rev ($mm)
$340
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 7/30/2019 via GlobeNewswire

Dedalus France, acquired Web100T

synopsis: Dedalus France (formerly Medasys), a major publisher of medical software, has acquired Web100T, a company that designs and distributes software packages for the health industry, hospitals and clinics for medical records and the regulation of stays, operating rooms and beds. Both companies are based in France.
buyer parent: Ardian
buyer: Dedalus France (ENXTPA:MED:$38.05)
Dedalus France (formerly Medasys) is a major publisher of software solutions in the areas of patient records, care production, biology, pathology, genetics and medical imaging, enabling healthcare institutions public and private to optimize and make reliable medical processes more efficient. "
target: Web100T
Web100T has been designing and distributing software packages for the health industry, hospitals and clinics for medical records and the regulation of stays, operating rooms and beds since 2003. They are based in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/21/2019 via Company Press Release

Ardian, will acquire Study Group International Ltd.

synopsis: Ardian, France's world-leading private investment house, announced it has reached an agreement to acquire a majority stake in Study Group, the leading provider of international education based in the UK, from Providence Equity Partners, a premier global asset management firm.
buyer: Ardian
Headquartered in France, Ardian is a world-leading private investment house with assets of $90bn managed or advised in Europe, the Americas and Asia. Ardian focuses on delivering excellent investment performance to its global investor base. "
target parent: Providence Equity Partners Inc.
target: Study Group International Ltd.
Study Group is a leading provider of international education. With 48 university partners around the world, it enables students to succeed at any degree level, by helping them develop the necessary study and language skills to which they may not have had access in their local education systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2018 via PE Hub

Corsair Capital, acquired RGI S.P.A.

synopsis: Ardian has sold RGI to Corsair Capital. RGI, of Milan, provides software products and technology services to the insurance industry. RGI is a provider of core systems to the insurance market, providing a comprehensive offering which addresses core insurance processes including policy administration, and market management.
buyer: Corsair Capital
Corsair Capital is one of the longest-standing private equity firms focused on investing in the financial services industry. Launched in 1992 in the aftermath of the U.S. savings and loan crisis, Corsair was the first fund of its size to invest in the financial services industry. "
target parent: Ardian
target: RGI S.P.A.
RGI, of Milan, provides software products and technology services to the insurance industry. RGI is a provider of core systems to the insurance market, providing a comprehensive offering which addresses core insurance processes including policy administration, and market management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/29/2017 via Company Press Release

Ardian, will acquire Competence Call Center Group (CCC)

synopsis: Ardian, the independent private investment company, has signed an agreement to acquire Competence Call Center Group (CCC), one of the leading BPO service providers in Europe.
buyer: Ardian
Ardian is a private investment house with assets of US$66bn managed or advised in Europe, North America and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base. "
target parent: Silverfleet Capital
target: Competence Call Center Group (CCC)
Competence Call Center Group (CCC) is one of the leading BPO service providers in Europe. Founded in Austria in 1998, CCC is today headquartered in Berlin. and offers high-quality BPO solutions in 28 languages and serves more than 80 customers in Europe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/28/2017 via GlobeNewswire

Medasys, acquired Netika SAS

synopsis: Medasys, a company that offers software solutions to the Patient Records, care provision, Biology and Medical Imaging departments of private and public sector healthcare institutions, has acquired Netika, a company that specializes in software for quality assurance and management of laboratory information systems.
buyer parent: Ardian
buyer: Medasys (ENXTPA:MED:$38.05)
Medasys has been supporting the performance, quality and innovation of private and public healthcare institutions for almost 30 years, providing them with proven solutions in the Patient Records, care provision, Biology and Medical Imaging departments. "
target: Netika SAS
Netika is a French IT services provider, based in Strasbourg, dedicated to the medical sector since 2000. With more than 2,200 health institutions that trust it, Netika is a key player for medical laboratories, but is opening to new medical domains such as medical imaging and radiotherapy.
price ($mm)
$11
rev ($mm)
$7
EBITDA ($mm)
$1
EV / rev
1.6x
EV / EBITDA
9.8x
closed 6/16/2017 via Company Press Release

Gantner Technologies, acquired Syx Automations BVBA

synopsis: GANTNER Electronic Austria Holding GmbH, a high-tech company specializing in electronic access control and staff time recording systems, announced its acquisition of Syx Automations NV of Belgium, a market leader in the field of ticketing and leisure facility management software solutions in the Benelux countries.
buyer parent: Ardian
buyer: Gantner Technologies
Founded in 1982 and headquartered in Schruns, Austria, Gantner is a leading international manufacturer of contactless RFID and NFC access control and staff time recording systems facilitating automatic identification. "
target parent: Sofindev Management NV
target: Syx Automations BVBA
Syx Automations, with headquarters in Ypres (Belgium) and offices in Houten (Netherlands), London (UK) and Ahmedabad (India), has been providing ticketing and leisure management solutions for the arts and cultural sector, visitor attractions and leisure industry customers for 30 years.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2017 via PE Hub

Forterro Inc., acquired Clip Industrie

synopsis: Forterro, a group of software companies that deliver strong operational ERP functionality to specialized geographical or vertical markets, has acquired Clip Industrie, a provider of computer-aided production management software for industrial small to medium-sized businesses.
buyer parent: Battery Ventures
buyer: Forterro Inc.
Forterro is a group of software companies that deliver strong operational ERP functionality to specialized geographical or vertical markets. The Forterro portfolio of ERP software solutions serves more than 3,000 customers around the world. "
target parent: Ardian
target: Clip Industrie
Clip Industrie is a leading publisher and integrator of computer-aided production management (CAPM) software for industrial SMEs. Its two vertical ERP software packages, Clipper and Helios, meet the needs of industrial companies in the aeronautics, automotive, medical, rail and watch making sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/29/2016 via Company Press Release

RGI S.P.A., will acquire Kapia Solutions

synopsis: RGI, the EMEA leader in the provision of software products and technological services specifically for the insurance sector, is set to strengthen its position in the IT Insurance French market, and agreed to acquire the 100% of Kapia, a French Software Vendor leader in Life, Pension & Wealth Management.
buyer parent: Ardian
buyer: RGI S.P.A.
RGI Group is one of the most dynamic information and communications technology (ICT) companies in Italy, with a proven leadership position in the provision of software, consulting and outsourcing services specifically for the insurance industry. "
target: Kapia Solutions
Kapia Solutions provides knowledge asset solutions for professional insurance applications. It offers consulting and engineering tailor made solutions that include Kapia Enhanced Life Insurance Simulation, an insurance simulation solution that simulates, compares, analyzes, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2016 via PE Hub

Ardian, GHO Capital, acquired Envision Pharma, Inc.

synopsis: Leading middle-market private equity firm, The Halifax Group, announced that it has sold Envision Pharma Group to Ardian and GHO Capital. Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
buyer: Ardian
buyer: GHO Capital
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. Global Healthcare Opportunities, or GHO Capital, was founded in 2014 as a specialist healthcare investment adviser based in London. "
target parent: Halifax Group
target: Envision Pharma, Inc.
Envision is a recognized strategic partner for Medical Affairs teams within biopharma, providing scientific data communication services and industry-leading technology solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/8/2016 via BNC Analysis

Ardian, acquired Dedalus S.p.A.

synopsis: Asset manager Ardian has acquired about 60% of Dedalus Holding, an international leader in providing healthcare IT software and solutions. Founded in 1990 in Florence, Italy, Dedalus encompasses 14 offices in Italy and 15 offices in Europe, Asia, Africa and the Americas.
buyer: Ardian
Ardian is an independent private investment company with assets of US$55bn managed or advised in Europe, North America and Asia. The company, which is majority-owned by its employees, keeps entrepreneurship at its heart and delivers investment performance to its global investors. "
target: Dedalus S.p.A.
Dedalus S.p.A. is an international leader in providing healthcare IT software and solutions. Founded in 1990 in Florence, Italy, Dedalus encompasses 14 offices in Italy and 15 offices in Europe, Asia, Africa and the Americas.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2011 via BNC Analysis

Crédit Agricole SA, will acquire Skyrock

synopsis: AXA Private Equity, a unit of French insurer AXA SA, announced the sale of a 53% stake in radio station Skyrock to French bank Credit Agricole SA. Credit Agricole will team up with Pierre Bellanger, the founder of Skyrock, in a holding that will control the radio station.
buyer: Crédit Agricole SA
Retail bank leader in France, Crédit Agricole is a first-class partner for the economies in which it operates. The strength of its retail banks worldwide and the expertise of its specialised subsidiaries give Crédit Agricole an effective presence in all areas of banking and finance. "
target parent: AXA Group
target: Skyrock
Skyrock is a hip hop-oriented radio station based in Paris, France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/19/2010 via Company Press Release

AXA Private Equity, will acquire Go Voyages

synopsis: AXA Private Equity, the leading European diversified private equity firm, announces that it has signed an agreement to acquire GO Voyages, the French online leader in the sale of air tickets.
buyer parent: AXA Group
buyer: AXA Private Equity
AXA Private Equity independently manages and/or advises Private Equity funds. It focuses on investments in unlisted companies and its expertise spans all types of Private Equity: Direct Funds, Funds of Funds and Private Equity Management Mandates. "
target parent: European Capital
target: Go Voyages
GO Voyages is France’s leading online seller of air tickets. GO Voyages also sells holidays and a full range of travel products (dynamic packages, city breaks, hotels, car hire, cruises, etc.)
price ($mm)
$358*
rev ($mm)
$1,284
EBITDA ($mm)
EV / rev
0.4x
EV / EBITDA
closed 6/6/2007 via Market Wire

AXA Private Equity, acquired Welcome Real-time

synopsis: In a management buyout, AXA Private Equity has acquired the majority of the shares of Welcome Real-time, a global provider of payment software for financial institutions and payment networks. The remaining shares were purchased by the current management team.
buyer parent: AXA Group
buyer: AXA Private Equity
AXA Private Equity independently manages and/or advises Private Equity funds. "
target: Welcome Real-time
Welcome Real-time is the leader in card marketing enhancements that create added value at the moment of payment. Welcome Real-time adds value to the traditional payment transaction through an enhanced payment experience that provides benefits to cardholders, retailers and financial institutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/27/2006 via Company Press Release

AXA Private Equity, will acquire Orbus

synopsis: AXA Private Equity has just signed an acquisition agreement – in association with Pierre Bellanger, CEO of Group Skyrock - with Tamago, the company held by Morgan Grenfell Private Equity and Goldman Sachs, for an 80% stake in Skyrock Group.
buyer parent: AXA Group
buyer: AXA Private Equity
AXA Private Equity independently manages and/or advises Private Equity funds. "
target: Orbus
Orbus operates French radion station Skyrock and Europe's No. 1 blog site Skyblog.
price ($mm)
$96
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Envision Pharma, Inc.


read more

Envision Pharma, Inc.

Envision Pharma Group

Envision Pharma, Inc.

Envision Pharma, Inc.

Medimix International

GeneEd, Inc.

Snapworx, LLC

SelectScience

Russell Publishing LLC

Pharmalot

OpenHelix, LLC

BioWorld

Bio-IT World

Dymaxium, Inc.

Fingertip Formulary

Nucleus Global

Genomeweb LLC

Exco InTouch, Ltd.

CenterWatch, Inc.

Virtual Clinical Solutions, Inc.

read more

doDOC Corp.

Envision Pharma Group

90Ten

Envision Pharma, Inc.

Envision Pharma, Inc.

Envision Pharma, Inc.

read more

PRGX Global, Inc.

AD Education SAS

Envision Pharma Group

DXC Technology Company

90Ten

Competence Call Center Group (CCC)

Web100T

Study Group International Ltd.

RGI S.P.A.

Competence Call Center Group (CCC)

Netika SAS

Syx Automations BVBA

Clip Industrie

Kapia Solutions

Envision Pharma, Inc.

Dedalus S.p.A.

Skyrock

Go Voyages

Welcome Real-time

Orbus

read more
Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3.com
M3.com
M3.com is Japan's largest portal site dedicated to healthcare professionals. M3.com provides the latest medical news, overseas journal article summaries, and medical resources. The portal offers information on clinical trials and other services in the healthcare and pharmaceutical industries.
year
2019
rev ($mm)
$1,015.17
EBITDA ($mm)
$288.13
EBIT ($mm)
$275.64
Net Income ($mm)
$175.78
Employees
5165
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate Analytics
Clarivate Analytics
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management.
year
2021
rev ($mm)
$1,441.88
EBITDA ($mm)
$460.43
EBIT ($mm)
$77.06
Net Income ($mm)
Employees
8568
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2020
rev ($mm)
$15.41
EBITDA ($mm)
($7.76)
EBIT ($mm)
($7.93)
Net Income ($mm)
Employees
163
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: PRSC
 
 
 
 
 
 
 
 
The Providence Service Corporation
The Providence Service Corporation
Providence Service Corporation, through its owned and managed entities, provides home and community based social services to government sponsored clients under programs such as welfare, juvenile justice, Medicaid and corrections.
year
2021
rev ($mm)
$1,454.99
EBITDA ($mm)
$190.61
EBIT ($mm)
$155.98
Net Income ($mm)
$91.58
Employees
17500
  • drill down
  • watch
Ticker: DFM:AMANAT
 
 
 
 
 
 
 
 
Amanat Holdings PJSC
Amanat Holdings PJSC
Dubai-based Amanat is a new kind of investment company that invests in health and education. Amanat works with like-minded business champions, providing long-term partnership, building long-term collaboration, and generating long-term sustainable value.
year
2019
rev ($mm)
$38.69
EBITDA ($mm)
($2.11)
EBIT ($mm)
($6.34)
Net Income ($mm)
$16.34
Employees
0
  • drill down
  • watch
Ticker: AIM:NSCI
 
 
 
 
 
 
 
 
NetScientific
NetScientific
NetScientific is a transatlantic healthcare IP commercialisation group. They fund and develop companies that significantly improve the health and well-being of people with chronic diseases.
year
2018
rev ($mm)
$0.45
EBITDA ($mm)
($10.78)
EBIT ($mm)
($11.09)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SEHK:575
 
 
 
 
 
 
 
 
Regent Pacific Group Limited
Regent Pacific Group Limited
Regent Pacific is a diversified investment group based in Hong Kong currently holding various corporate and strategic investments focusing on the healthcare, wellness and life sciences sectors.
year
2020
rev ($mm)
EBITDA ($mm)
($5.71)
EBIT ($mm)
($33.93)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: OB:CARA
 
 
 
 
 
 
 
 
Carasent
Carasent
Carasent is an investment management company in Norway that focuses on businesses that develop entrepreneurial and e-health solutions. Carasent's strategy is to continue to develop and expand digitalization that helps customers to meet challenges in providing efficient health care services.
year
2020
rev ($mm)
$7.42
EBITDA ($mm)
$1.57
EBIT ($mm)
$1.02
Net Income ($mm)
Employees
51
  • drill down
  • watch
Ticker: CNSX:AUSA
 
 
 
 
 
 
 
 
Australis Capital Inc.
Australis Capital Inc.
Australis Capital (AUSA) operates and builds transformative, differentiated cannabis companies predominantly in the United States, a highly-regulated, fragmented, and rapidly expanding industry. AUSA adheres to stringent evaluation and operating criteria focusing on high-quality opportunities.
year
2019
rev ($mm)
$0.19
EBITDA ($mm)
($7.49)
EBIT ($mm)
($7.51)
Net Income ($mm)
$3.87
Employees
0
  • drill down
  • watch
Ticker: CSE:GHG
 
 
 
 
 
 
 
 
Global Hemp Group Inc.
Global Hemp Group Inc.
Global Hemp Group (“GHG”) is a publicly traded company founded in 2012. The Company is focused on acquiring and/or joint venturing with companies across all sectors of the hemp and cannabis industries.
year
2014
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($1.92)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: NYSE:OHI
 
 
 
 
 
 
 
 
Omega Healthcare Investors, Inc.
Omega Healthcare Investors, Inc.
Omega Healthcare Investors is a triple-net, equity REIT (NYSE: OHI) that supports the goals of Skilled Nursing Facility (SNF) and Assisted Living Facility (ALF) operators with financing and capital. They're partners with 69 of the most future-focused, growth-oriented operators in the U.S. and U.K.
year
2020
rev ($mm)
$892.38
EBITDA ($mm)
$770.19
EBIT ($mm)
$454.45
Net Income ($mm)
$159.33
Employees
0
  • drill down
  • watch